| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Catheter Precision, Inc.: New LockeT Data Accepted in Leading Electrophysiology Journal | 2 | GlobeNewswire (USA) | ||
| 03.04. | Catheter Precision looks to sell cardiac EP business, move into aviation | 2 | MassDevice | ||
| 02.04. | Catheter Precision sucht Käufer für Medizintechnik-Sparte | 1 | Investing.com Deutsch | ||
| 31.03. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | Catheter Precision, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 31.03. | Catheter Precision reports Q4 results | 6 | Seeking Alpha | ||
| 31.03. | Catheter Precision, Inc.: Catheter Precision Reports 2025 Results and Updates on Strategic Expansion | 152 | GlobeNewswire (Europe) | Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital... ► Artikel lesen | |
| 25.03. | Catheter Precision, Inc.: Flyte Hops: Vision Jet Platform Seeks to Redefine Private Aviation | 1 | GlobeNewswire (USA) | ||
| 11.03. | Catheter Precision secures up to $88M in strategic financing | 2 | Seeking Alpha | ||
| 11.03. | Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth | 188 | GlobeNewswire (Europe) | FORT MILL, S.C., March 11, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced transformational balance sheet improvements through new institutional capital commitments... ► Artikel lesen | |
| 10.03. | Catheter Precision Jumps On Acquiring Fly Flyte From Creatd | - | RTTNews | ||
| 10.03. | Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity | 1 | Seeking Alpha | ||
| 09.03. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.03. | Catheter Precision, Inc.: Catheter Precision's LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026 | 1 | GlobeNewswire (USA) | ||
| 19.02. | Catheter Precision to sell atherectomy catheter assets, focus on electrophysiology | 1 | MassDevice | ||
| 19.02. | Catheter Precision Divests Non-Core Assets As It Shifts Focus | 1 | Benzinga.com | ||
| 19.02. | Catheter Precision, Inc.: Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth | 831 | GlobeNewswire (Europe) | FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive... ► Artikel lesen | |
| 17.02. | Catheter Precision acquires 20% stake in Creatd's aviation subsidiary | 1 | Investing.com | ||
| 17.02. | Catheter Precision steigt mit 20 % bei Luftfahrt-Tochter von Creatd ein | 2 | Investing.com Deutsch | ||
| 17.02. | CREATD INC.: VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. | 124 | GlobeNewswire (Europe) | Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,700 | +0,45 % | Fresenius: S&P Global erhöht Ausblick - jetzt zugreifen? | Unter der Leitung von Konzernchef Michael Sen hat sich Fresenius einem Umbau unterzogen. Randbereiche wurden verkauft, die Effizienz gesteigert und schlussendlich auch der Schuldenabbau forciert. Das... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,340 | +0,75 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,620 | +1,74 % | Eckert & Ziegler erhält MDR-Zertifizierung für Augentumorbehandlung | Die Eckert & Ziegler BEBIG GmbH, eine auf Brachytherapie spezialisierte Tochtergesellschaft der Eckert & Ziegler SE, hat die MDR-Zertifizierung der EU für ihre Ruthenium-106-Augenapplikatoren erhalten.... ► Artikel lesen | |
| BICO GROUP | 1,668 | -0,36 % | BICO Group AB: BICO Group AB has divested the Finnish property for a total of EUR 3.5m | BICO Group AB ("BICO") has completed the divestment of its property in Oulu, Finland, through the sale of BICO Real Estate Oy to Logistea AB ("Logistea"). The total sales price amounts to EUR 3.5m,... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,098 | -4,93 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 9, 2026) - Sernova Biotherapeutics Inc. (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative... ► Artikel lesen | |
| CARDINAL HEALTH | 183,65 | -0,05 % | Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now | ||
| RESMED | 194,70 | -0,23 % | RESMED INC: 4 Statement of changes in beneficial ownership | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update | SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| ZIMMER BIOMET | 79,72 | +0,38 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer | Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity WARSAW, Ind., April 7,... ► Artikel lesen | |
| UNIDOC HEALTH | 0,057 | -9,46 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharma schließt Produktions- und Liefervereinbarung mit Kenvue Brands | ||
| CO-DIAGNOSTICS | 1,400 | -5,41 % | Co-Diagnostics Reports Full Year 2025 Financial Results | Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures
Progressing Clinical Pipeline and Regulatory Pathways for PCR Platform
Strengthening... ► Artikel lesen | |
| CYTOSORBENTS | 0,555 | +5,71 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights | 2025 revenue of $37.1 million, up 4% year-over-year, and 71% Full-year gross margins
Enhanced Balance Sheet Flexibility with an Additional $2.5 million Proceeds... ► Artikel lesen | |
| VERU | 2,380 | -2,06 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| SENSEONICS | 5,950 | +4,39 % | A look at the tech behind the world's first year-long CGM with Senseonics |